Patel Chem approves director re-appointment, sets AGM for September 25
- Re-appointed Mrs. Anshu Bhupesh Patel as director
- Fixed AGM date for September 25, 2026
- Set record date for AGM as September 18, 2026
- Approved FY26 Directors Report and Secretarial Audit Report

*this image is generated using AI for illustrative purposes only.
Patel Chem Specialties approved the re-appointment of Mrs. Anshu Bhupesh Patel as a director and fixed its annual general meeting for September 25, 2026.
The Board of Directors held its meeting on Tuesday, September 1, 2026, at 11:00 am. The session concluded at 12:00 noon. The board considered and approved the Directors Report for the financial year ended March 31, 2026.
Key Resolutions
The board transacted the following items of business during the meeting:
- Director Re-appointment: Recommended the re-appointment of Mrs. Anshu Bhupesh Patel (DIN: 02148403), who retires by rotation.
- AGM Details: Fixed the date, time, and venue for the 18th Annual General Meeting. The AGM will be held on September 25, 2026, at 11:00 am at the company's registered office.
- Record Date: Determined the record date for the AGM as September 18, 2026.
- Approvals: Approved the Draft Notice for the AGM and the Secretarial Auditor's Report for FY25-26.
- Scrutinizer: Appointed M/s. RTBR & Associates, Practicing Company Secretaries, as Scrutinizer for the e-voting and poll paper voting processes.
The intimation was issued pursuant to Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015.
Historical Stock Returns for Patel Chem Specialities
| 1 Day | 5 Days | 1 Month | 6 Months | 1 Year | 5 Years |
|---|---|---|---|---|---|
| +1.37% | +6.85% | +17.49% | +63.62% | +13.16% | 0.0% |
How might the re-appointment of Mrs. Anshu Bhupesh Patel influence Patel Chem Specialties' strategic direction and corporate governance stability in the coming fiscal year?
What key financial performance metrics or operational highlights are expected to be detailed in the Directors Report for FY25-26, and how do they compare to previous years?
Are there any significant regulatory compliance issues or observations highlighted in the Secretarial Auditor's Report for FY25-26 that could impact investor confidence?


































